As illustrated on Slide 12, our balance sheet remains healthy with $148,000,000 of cash, short term and long term investments and just $2,100,000 of debt. We had $1,200,000 in capital expenditures in the quarter, mainly to support our manufacturing operations and $5,600,000 year to date. Our inventory balance decreased from $84,000,000 at the end of Q2 of fiscal 2024 to $75,000,000 in the Q3 of fiscal 2024. Our cash, short term and long term investments reflect a net reduction of just $1,000,000 from March 31, of which $5,500,000 was associated with of shares in the Q3. We recorded positive cash flow from operations of approximately $3,900,000 in the 3rd quarter and year to date, we have generated $8,500,000 from operations, mainly due to a reduction in inventory of approximately $9,000,000 in the quarter and $23,000,000 year to date.